Wikidata

(Q34572496)

English

Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism

scientific article

In more languages

Statements

title
Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
author name string
Arthur L Burnett
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
Trinity J Bivalacqua
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
Hunter C Champion
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
Biljana Musicki
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
publication date
1 November 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017
page(s)
1077-1084
1 reference
stated in
Europe PubMed Central
PubMed ID
17100941
retrieved
3 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34572496&oldid=1979858312"